Executive function

Handbook of Experimental Pharmacology

Volumn 228, Issue , 2015, Pages 191-213

  Talpos, John ^a   Shoaib, Mohammed ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cognitive flexibility; Executive function; Prefrontal cortex; Reversal learning

Indexed keywords

5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; AMPHETAMINE; ASENAPINE; ATOMOXETINE; CLOZAPINE; DOPAMINE; GLUTAMATE RECEPTOR; KETAMINE; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NICOTINE; PHENCYCLIDINE; SEROTONIN; TACRINE; VOLINANSERIN; NOOTROPIC AGENT;

ARTICLE; ATTENTION; ATTENTIONAL FLEXIBILITY; ATTENTIONAL SET SHIFTING TASK; COGNITION; COGNITIVE DEFECT; DISCRIMINATION LEARNING; DRUG ACTIVITY; EXECUTIVE FUNCTION; EXTRADIMENSIONAL SET SHIFTING; LEARNING; NEURAL SUBSTRATE; NEUROBIOLOGY; NEUROSCIENCE; NONHUMAN; ORBITAL CORTEX; POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RECOGNITION; RODENT; SCHIZOPHRENIA; VALIDITY; VISUAL DISCRIMINATION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; HUMAN; MENTAL DISORDERS; METABOLISM; NERVE CELL PLASTICITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EXECUTIVE FUNCTION; HUMANS; LEARNING; MENTAL DISORDERS; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PREDICTIVE VALUE OF TESTS;

EID: 84929377585     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-319-16522-6_6     Document Type: Article

References (76)

1. Allison C, Shoaib M (2013) Nicotine improves performance in an attentional set shifting task in rats. Neuropharmacology 64: 314-320.
2. Asari T, Konishi S, Jimura K, Miyashita Y (2005) Multiple components of lateral posterior parietal activation associated with cognitive set shifting. Neuroimage 26(3): 694-702.
3. Barak S, Weiner I (2011) Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Pharmacol Biochem Behav 99(2): 164-189.
4. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34: 1161-1177.
5. Berg EA (1948) A simple objective technique for measuring flexibility in thinking. J Gen Psychol 39: 15-22.
6. Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20(11): 4320-4324.
7. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM (2008) Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 28(44): 11124-11130.
8. Boulougouris V, Robbins TW (2009) Pre-surgical training ameliorates orbitofrontal-mediated impairments in spatial reversal learning. Behav Brain Res 197: 469-475.
9. Boulougouris V, Robbins TW (2010) Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. J Neurosci 30: 930-938.
10. Boulougouris V, Dalley JW, Robbins TW (2007) Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res 179: 219-228.
11. Boulougouris V, Castane A, Robbins TW (2009) Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology (Berl) 202: 611-620.
12. Brigman JL, Feyder M, Saksida LM, Bussey TJ, Mishina M, Holmes A (2008) Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn Mem 15: 50-54.
13. Brigman JL, Mathur P, Harvey-White J, Izquierdo A, Saksida LM, Bussey TJ, Fox S, Deneris E, Murphy DL, Holmes A (2010) Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex 20: 1955-1963.
14. Brigman JL, Daut RA, Wright T, Gunduz-Cinar O, Graybeal C, Davis MI, Jiang Z, Saksida LM, Jinde S, Pease M, Bussey TJ, Lovinger DM, Nakazawa K, Holmes A (2013) GluN2B in corticostriatal circuits governs choice learning and choice shifting. Nat Neurosci 16: 1101-1110.
15. Broadbent NJ, Squire LR, Clark RE (2007) Rats depend on habit memory for discrimination learning and retention. Learn Mem 14: 145-151.
16. Brown VJ, Bowman EM (2002) Rodent models of prefrontal cortical function. Trends Neurosci 25 (7): 340-343.
17. Chase EA, Tait DS, Brown VJ (2012) Lesions of the orbital prefrontal cortex impair the formation of attentional set in rats. Eur J Neurosci 36(3): 2368-2375.
18. Chen KC, Baxter MG, Rodefer JS (2004) Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting. Eur J Neurosci 20: 1081-1088.
19. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC (2005) Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 25: 532-538.
20. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC (2007) Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex 17: 18-27.
21. Clarke HF, Robbins TW, Roberts AC (2008) Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 28: 10972-10982.
22. Clarke HF, Hill GJ, Robbins TW, Roberts AC (2011) Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus. J Neurosci 31: 4290-4297.
23. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29: 4690-4696.
24. Cools R, Clark L, Owen AM, Robbins TW (2002) Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 22 (11): 4563-4567.
25. Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW (2007) L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32: 180-189.
26. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28(7): 771-784.
27. Dias R, Robbins TW, Roberts AC (1996a) Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380(6569): 69-72.
28. Dias R, Robbins TW, Roberts AC (1996b) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 110 (5): 872-886.
29. Dias R, Robbins TW, Roberts AC (1997) Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing. J Neurosci 17(23): 9285-9297.
30. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12): 6917-6922.
31. Egerton A, Brett RR, Pratt JA (2005a) Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility. Neuropsychopharmacology 30 (10): 1895-1905.
32. Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA (2005b) Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology (Berl) 179(1): 77-84.
33. Fellini L, Kumar G, Gibbs S, Steckler T, Talpos J (2014) Re-evaluating the PCP challenge as a preclinical model of impaired cognitive flexibility in schizophrenia. Eur Neuropsychopharmacol 24(11): 1836-1849. doi: 10. 1016/j. euroneuro. 2014. 08. 012.
34. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S (2005) Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 183(2): 190-200.
35. Floresco SB, Jentsch JD (2011) Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 36(1): 227-250.
36. Fox MT, Barense MD, Baxter MG (2003) Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of posterior parietal cortex. J Neurosci 23(2): 676-681.
37. Frohlich J, Van Horn JD (2014) Reviewing the ketamine model for schizophrenia. J Psychopharmacol 28(4): 287-302.
38. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD (2011) Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci 31: 7291-7299.
39. Haluk DM, Floresco SB (2009) Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 34: 2041-2052.
40. Hampshire A, Owen AM (2006) Fractionating attentional control using event-related fMRI. Cereb Cortex 16: 1679-1689.
41. Hornak J, O'Doherty J, Bramham J, Rolls ET, Morris RG, Bullock PR, Polkey CE (2004) Rewardrelated reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 16: 463-478.
42. Keeler JF, Robbins TW (2011) Translating cognition from animals to humans. Biochem Pharmacol 81(12): 1356-1366.
43. Lapiz MD, Bondi CO, Morilak DA (2007) Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test. Neuropsychopharmacology 32(5): 1000-1010.
44. Lapiz MD, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137(3): 1039-1049.
45. Lee B, Groman S, London ED, Jentsch JD (2007) Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 32: 2125-2134.
46. Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TR, Joyce EM (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66(6): 586-593.
47. Lindgren HS, Wickens R, Tait DS, Brown VJ, Dunnett SB (2013) Lesions of the dorsomedial striatum impair formation of attentional set in rats. Neuropharmacology 71: 148-153.
48. McAlonan K, Brown VJ (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146(1-2): 97-103.
49. McGaughy J, Ross RS, Eichenbaum H (2008) Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 153(1): 63-71.
50. McLean SL, Idris NF, Grayson B, Gendle DF, Mackie C, Lesage AS, Pemberton DJ, Neill JC (2012) PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. J Psychopharmacol 26(9): 1265-1270.
51. Milner B (1963) Effects of different brain lesions on card sorting. Arch Neurol 9: 100-110.
52. Muller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64: 490-495.
53. Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128(3): 419-432.
54. Newman LA, Darling J, McGaughy J (2008) Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology (Berl) 200 (1): 39-50.
55. Ng CW, Noblejas MI, Rodefer JS, Smith CB, Poremba A (2007) Double dissociation of attentional resources: prefrontal versus cingulate cortices. J Neurosci 27(45): 12123-12131.
56. Nikiforuk A, Popik P (2012) Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology (Berl) 220(1): 65-74.
57. Nikiforuk A, Gołembiowska K, Popik P (2010) Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. Eur Neuropsychopharmacol 20(1): 37-48.
58. Normans DA, Shallice T (1980) Attention to action: willed and automatic control of behavior. In: Gazzaniga MS (ed) Cognitive neuroscience: a reader. Blackwell, Oxford.
59. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991) Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29(10): 993-1006.
60. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33: 575-588.
61. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5: 266-281.
62. Roberts AC, Wallis JD (2000) Inhibitory control and affective processing in the prefrontal cortex: neuropsychological studies in the common marmoset. Cereb Cortex 10: 252-262.
63. Roberts AC, Robbins TW, Everitt BJ, Jones GH, Sirkia TE, Wilkinson J, Page K (1990) The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets. Neuroscience 34: 311-329.
64. Roberts AC, Robbins TW, Everitt BJ, Muir JL (1992) A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 47(2): 251-264.
65. Rodefer JS, Nguyen TN, Karlsson JJ, Arnt J (2008) Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology 33(11): 2657-2666.
66. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JF, Sahakian BJ, Robbins TW (1999a) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-339.
67. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW (1999b) Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) 146: 482-491.
68. Rygula R, Walker SC, Clarke HF, Robbins TW, Roberts AC (2010) Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 30: 14552-14559.
69. Schoenbaum G, Nugent SL, Saddoris MP, Setlow B (2002) Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport 13(6): 885-890.
70. Seu E, Jentsch JD (2009) Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats. Neuropharmacology 57(7-8): 665-672.
71. Tait DS, Brown VJ, Farovik A, Theobald DE, Dalley JW, Robbins TW (2007) Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. Eur J Neurosci 25 (12): 3719-3724.
72. Tait DS, Brown VJ (2008) Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats. Behav Brain Res 187(1): 100-108.
73. Tait DS, Chase EA, Brown VJ (2013) Tacrine improves reversal learning in older rats. Neuropharmacology 73: 284-289.
74. Talpos J, Steckler T (2013) Touching on translation. Cell Tissue Res 354: 297-308.
75. Waltz JA, Gold JM (2007) Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 93(1-3): 296-303.
76. Wood S, Sage JR, Shuman T, Anagnostaras SG (2014) Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev 66: 193-221.